KTH-222 / Kalos Therap, Oncology Pharma - LARVOL DELTA

A novel, small peptide with activity against human pancreatic cancer. (PubMed, Am J Cancer Res) - "In this model system, KTH-222 is more effective than gemcitabine, a drug commonly used in the treatment of pancreatic cancer. Furthermore, KTH-222 does not decrease the rate of weight gain in the treated mice, suggesting the absence of gross toxicity. These activities of KTH-222 suggest that it may be useful in the treatment of pancreatic cancer."

Journal • Gastrointestinal Cancer • Oncology • Pancreatic Cancer • Solid Tumor